Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Iloperidone LAI by Vanda Pharmaceuticals for Schizophrenia: Likelihood of Approval
Iloperidone LAI is under clinical development by Vanda Pharmaceuticals and currently in Phase II for Schizophrenia. According to GlobalData, Phase...